Abstract: An ambulatory infusion device for the infusion of a liquid drug into a patient's body over an extended time period includes an infusion cannula designed to be placed in the patient's subcutaneous tissue. At least two subcutaneous electrodes are comprised by the infusion cannula and are placed in the subcutaneous tissue. An impedance measuring unit is operatively coupled to the at least two electrodes and is configured to measure at least one impedance value between the at least two electrodes. A variation of the at least one impedance value reflects a displacement of interstitial fluid by drug upon drug administration. An event trigger unit is operatively coupled to the impedance measuring unit and being configured to evaluate the at least one impedance value and to generate an event trigger if evaluation of the at least one impedance value indicates the occurrence of an administration anomaly.

Abstract: Included are embodiments of an ambulatory infusion device. Some embodiments include an energy storage for storing electrical energy utilized for powering the ambulatory infusion device. The energy storage may serve as a primary power source of the ambulatory infusion device. Also included is a dosing unit with an electrically powered actuator and an electronic controller, where the electronic controller controls operation of the electrically powered actuator. Some embodiments also include a testing unit for testing the energy storage. The testing unit may be configured to repeatedly carry out a test during operation of the ambulatory infusion device. Additionally, the test may include determining a control variable, the control variable being indicative of a capability of the energy storage for further powering the ambulatory infusion device.

Abstract: An ambulatory infusion device for the infusion of a liquid drug into a patient's body over an extended time period includes an infusion cannula designed to be placed in the patient's subcutaneous tissue. At least two subcutaneous electrodes are comprised by the infusion cannula and are placed in the subcutaneous tissue. An impedance measuring unit is operatively coupled to the at least two electrodes and is configured to measure at least one impedance value between the at least two electrodes. A variation of the at least one impedance value reflects a displacement of interstitial fluid by drug upon drug administration. An event trigger unit is operatively coupled to the impedance measuring unit and being configured to evaluate the at least one impedance value and to generate an event trigger if evaluation of the at least one impedance value indicates the occurrence of an administration anomaly.